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• There is sufficient evidence to warrant recommendation of group exercise therapy 
for stress incontinence in older women 
• There is sufficient evidence to warrant recommendation of behavioural therapy for 
older women with any incontinence type 
• Evidence was insufficient to recommend any non-pharmacological therapy for men 
with urinary incontinence 
• Evidence was insufficient to recommend any other type of non-pharmacological 






Background: Urinary incontinence is especially common in older age. Non-
pharmacological therapies are particularly desirable in this group.  
Objective: To define optimal evidence-based non-pharmacological, non-surgical therapies 
for urinary incontinence in older persons.  
Methods: A Delphi process determined critical outcome measures of interest. Studies of any 
non-pharmacological intervention reporting critical outcomes were identified through 
database searches for relevant systematic reviews in Medline, Embase, CINAHL, PsycInfo 
and Cochrane by June 2018. Primary trials with a population mean age ≥65years were 
identified with subsequent data extraction and risk of bias assessment. Qualitative analysis 
and meta-analysis, when possible, were undertaken followed by grading of the evidence 
using GradePro software. Finally, bullet-point recommendations were formulated for the 
indications and contraindications for non-pharmacological interventions for urinary 
incontinence in older persons.  
Results: Frequency of incontinence was identified as a critically important outcome. In 
total, 33 systematic reviews were identified with 27 primary trials meeting inclusion criteria. 
Evaluated therapies included exercise therapy, habit retraining, behavioural therapy, 
electrical stimulation, transcutaneous tibial nerve stimulation, magnetic stimulation, caffeine 
reduction and acupuncture. From meta-analysis, group exercise therapy and behavioural 
therapy in women were beneficial in reducing episodes of incontinence (mean reduction of 
1.07 (95%CI 0.69-1.45) and 0.74 (95%CI 0.42-1.06) episodes per day respectively, evidence 




Conclusions: There is sufficient evidence to warrant recommendation of group exercise 
therapy for stress incontinence and behavioural therapy for urgency, stress or mixed urinary 
incontinence in older women. Evidence was insufficient to recommend any other non-drug 
therapy. 
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Urinary incontinence primarily affects older people with current figures estimating that 
46% of women and 34% of men over the age of 80 are affected [1-3]. It is o f t e n  
termed one of the “geriatric giants” due to its high prevalence and considerable social and 
economic impact [2-4]. Furthermore, an estimated 65.7% of women and 58.3% of men with 
urinary incontinence find symptoms impact to some degree on their quality of life (QoL), 
particularly in older age [5-10]. 
 
Older people are also much more likely to experience an adverse drug reaction (ADR) 
[11], accounting for up to 31% of hospital admissions [12], causing significant 
morbidity and mortality in this group. Despite this, about half of all ADRs are 
preventable [13]. The crude prevalence of ADRs dramatically increases with age for two 
main reasons - polypharmacy and the altered physiology associated with ageing. This 
means non-pharmacological treatments are particularly appealing to use in this patient 
group. Moreover, more people with incontinence prefer non-pharmacological approaches 
to medical or surgical options [14]. Therefore, providing evidence-based recommendations 
for the use of non-pharmacological treatments in this age group specifically is important.  
 
The SENATOR consortium is an international collaborative group developing and trialing 
a Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in 
Older peRsons (SENATOR)  wi th in  an  FP7  funded  p ro j ect [15]. This software 
will assess multi-morbidity in older people and deliver bespoke i nd iv id ua l i z ed  
r ecom m en da t i ons  o n  t h e  optimal pharmacological and non-pharmacological 
treatment. Informing best practice for the SENATOR software recommendations on non-




in Older Persons (ONTOP) project [16]. The ONTOP project evaluates non-drug 
therapies in older persons through a specially developed methodology involving 
systematic reviews of the literature on prevalent conditions affecting elderly patients, 
including urinary incontinence. The ONTOP methodology results in brief, bullet-point 
recommendations of non-pharmacological treatment of c o m m o n  g e r i a t r i c  
s yn d r o m e s  that will inform the SENATOR software. Here, we describe the process for 





2.1.1 ONTOP Methodology 
The full methodology and protocol for the ONTOP series of reviews is published elsewhere 
[16]. Briefly, this involves using systematic reviews and meta-analyses as t h e  source of 
evidence for clinical recommendations. 
 
The first step is to identify those outcomes of highest clinical importance in order to 
focus the list of included studies. This was achieved by applying a Delphi Process to a 
list of outcomes deemed clinically relevant by a panel of 11 clinicians in geriatric 
medicine. Outcomes were rated anonymously and independently on a scale of 1-9 in the 
categories not important (1-3), important but not critical for making a decision (4-6) and 
critical for making a decision (7-9). Those outcomes rated as critical by the Delphi process 
were then used as the primary outcomes of interest in the literature being reviewed. 
Guidelines and review articles were included if they followed the set-up of a systematic 
review. The identified systematic reviews and meta-analyses were then used to identify 
primary studies for inclusion in this paper. Eligible papers had to include at least one 
primary study meeting inclusion criteria with the full text available in English. Primary 
studies had to be any type of comparative study, which included randomised 
controlled trails (RCTs) as well as quasi-experimental and pre/post intervention studies. 
Furthermore, only full texts in English were included as abstracts alone had insufficient 
evidence to allow assessment for inclusion as well as assessment of bias, meta-analysis 
and grading of evidence. In the event that data were not fully reported, attempts were 
made to contact the authors and request the additional information. 
 




Since SENATOR software is intended for use in those aged  65 years or over 
only,  a minimum mean age of ≥ 65 years was applied to participants of the primary 
studies. Studies investigating associated and specific conditions relating to incontinence 
were excluded, such as multiple sclerosis associated, post-prostatectomy and post-stroke 
urinary incontinence. 
 
Systematic reviews relating to any non-pharmacological, non-surgical treatments were 
eligible for inclusion, e.g. pelvic floor muscle training (PFMT) or acupuncture. These 
interventions could be delivered in a multicomponent nature, independently, in the 
community or in a tertiary care setting. Studies detailing other aspects of urinary 
incontinence, such as risk factors and investigations, were excluded. Containment 
methods e.g. pads, were deemed inappropriate for inclusion, as they were not considered 
an intervention since they would not ultimately change incontinent episodes.   Electrical   
stimulation   with   implantable   electrodes   e.g. percutaneous tibial nerve stimulation 
was also deemed inappropriate as this was regarded as an invasive technique. 
 
2.1.2 Search Methods 
Medline, Embase, PsycInfo, CINAHL and the Cochrane Library were used as the 
sources of systematic reviews for inclusion in this review. The source used to assist in 
defining the search strategies was the Cochrane Incontinence Group list for hand 
searchers [17] (see Supplementary Data, Appendix 1). There were no date restrictions set 
on the searches and records were searched from inception until 29th June 2018. 
 
Database searches were limited to English language and humans. However, the 




Cochrane reviews only, with exclusion of protocols. However, on screening the 
Cochrane Library results, the same limits were placed on the results as the other 
databases.  
 
Following duplicate removal, the results of the searches were screened by titles and 
abstracts, then by full texts to determine eligibility for inclusion. When there was an 
updated version of a systematic review, only the most recent publication was screened. On 
completion of screening of the systematic reviews, the primary studies included in the 
reviews were screened for inclusion eligibility and subsequently sourced. Furthermore, 
the reference lists of the included primary trials were also hand-searched to ensure 
thorough inclusion. Primary studies were included if they assessed any non-
pharmacological, non-surgical intervention with any control intervention (no intervention, 
usual care, placebo or sham interventions) and measured any outcome deemed of critical 
importance by the Delphi group in a population of mean age 65 years or over. 
 
Two independent reviewers undertook the searches and selections, with any disagreements 
between reviewers resolved by discussion, to produce a final list of literature for 
detailed review. Studies that used data that had already been included in another 
study were excluded. If any differences could not be resolved by discussion between 
the reviewers, a third reviewer was asked to determine eligibility for inclusion. All 
individuals involved completed training in the ONTOP methodology to ensure consistency 
of approach. 
 
2.1.3 Data Extraction and Analysis 
Following identification of primary papers for inclusion, data extraction was undertaken by 




the study design and participants as well as critical appraisal questions, allowing an initial 
assessment of the risk of bias in the included studies.  
 
The risk of bias in each study was assessed as per the Cochrane Handbook for systematic 
reviews [18] using risk of bias tables on RevMan5.3. The tables addressed the following 
seven sources of bias: 
• Random sequence generation 
• Allocation concealment 
• Blinding of participants and personnel  
• Blinding of outcome assessment 
• Incomplete outcome data 
• Selective reporting  
• Other biases 
These areas of bias were assigned low, high or, if there was insufficient evidence, unclear 
risk and allowed assessment of selection, performance, detection, attrition reporting and 
other biases.  
 
Meta-analysis was undertaken when possible, by intervention and outcome following the 
clinical questions previously mentioned. For eligibility for meta-analysis, studies had to be a 
comparative study and in the case of pre/post intervention studies the pre and post results 
were considered as control and experimental groups respectively. Furthermore, only studies 
where data were fully reported, or had been accessed through contacting authors, with a 
sample size, mean and standard deviation, were included. Individual forest plots were 





Grading of the evidence was done by intervention and outcome using the Grades of 
Recommendation, Assessment, Development and Evaluation (GRADE) Working Group 
approach on the GradePro Software, allowing subsequent recommendations regarding care 
to be made [19-22]. The GRADE approach involves assessing four areas of evidence, i.e. 
risk of bias, inconsistency, indirectness and imprecision. A summary of findings table was 
prepared using GradePro software and evidence was rated as high, moderate, low or very 
low quality allowing for an objective decision to be made regarding recommendations for 
care. From grading of evidence, practical bullet-point recommendations were made 
regarding the care of older people with urinary incontinence to be used in the ONTOP 





The results of the Delphi Process, applied to 11 identified outcomes, are shown in 
Supplementary Data Appendix 2. The number of episodes of incontinence per day was the 
only outcome rated as critical and hence was the only outcome of interest in this review. In 
the event that episodes of incontinence were reported per week, this was converted to 
episodes per day.  
 
The results from the database searches and the screening process are shown in the PRISMA 
flow diagram (Fig. 1). From the 2496 articles identified through database searching 
following duplicate removal, a total of 33 systematic reviews were identified with 27 
primary articles on eight different interventions were eligible for inclusion in this systematic 
review (see Supplementary data, Appendix 3 and 4).  
 
Of the 27 studies, 17 were RCTs, four were non-randomised quasi-experimental studies, five 
were pre/post intervention studies and one was a prospective case series. All the studies 
were community based, including outpatient clinics and nursing homes, and had sample 
sizes varying from 13 to 222 participants. The majority (N=19) were based in the USA and 
the others in Australia, China, Hong Kong, Iran, Japan, Portugal and Sweden. A total of 17 
studies consisted of women participants only, with men being the minority in the remaining 
10 studies. There were varying diagnoses among participants, with five studies including 
participants with urinary urgency incontinence (UUI) or urgency predominant mixed urinary 
incontinence only, three studies investigating participants with stress urinary incontinence 
(SUI) only and the rest investigating any type of urinary incontinence. The risk of bias 
assessment is shown in Supplementary data, Appendix 5. The highest risk areas of bias were 




the nature of the majority of the interventions, it would have been impossible to blind 
participants and personnel to the group allocation, hence major weight was given to the 
blinding of the outcome assessor during evidence assessment.  
 
The included studies investigated eight types of non-pharmacological, non-surgical 
interventions, which were:  
• Pelvic floor muscle training (7 studies) 
o Group exercise therapy (4 studies) 
o Individual pelvic floor muscle training (3 studies) 
• Bladder training (5 studies) 
• Behavioural therapy (10 studies) 
• Electrical stimulation (1 study) 
• Transcutaneous tibial nerve stimulation (1 study)  
• Non-invasive magnetic stimulation  (1 study) 
• Minimising caffeine consumption (1 study) 
• Acupuncture (1 study) 
Of these interventions, only group pelvic floor muscle training, behavioural therapy and 
bladder training provided sufficient evidence for use in meta-analysis of reducing the 
number of episodes of urinary incontinence in elderly people (Figures 2-4). Two studies on 
behavioural therapy (Burton et al 1998 and Jirovec et al 2017) and one on bladder training 
(Colling et al 1992) could not be included in the meta-analyses as their results were not 
presented as mean and standard deviations of episodes of incontinence per day.  The quality 
of evidence according to the GRADE classification is shown in Supplementary Data, 




treating urinary incontinence mainly due to a limitation in the number of studies, such that 
grading was only low or very low quality evidence. 
 
Therefore, a small number of ONTOP recommendations were produced from this review for 
use in the SENATOR software. The instructions are based on the interventions in the 
included studies.  
Recommendation 1- Group exercise therapy consisting of stretching exercises, PFMT and 
fitness exercises are recommended for older women with SUI in weekly sessions (strong 
recommendation based on moderate quality evidence).  
Recommendation 2- Combination behavioural therapy consisting of PFMT, bladder 
training and methods for managing SUI and UUI is recommended for older people with 
urinary incontinence (strong recommendation based on moderate quality evidence). 
• Bladder training consists of prompted or scheduled voiding every 1-hour, increasing 
by half an hour each week to a target of two and a half to three hours between voids. 
• PFMT consists of at least 15 contractions of pelvic floor muscles three times/day 
each lasting as close to 10 seconds as possible for the patient. This can be 
with/without biofeedback of any form, at the discretion of the clinician. 
• Instructions for managing incontinence: 
o UUI- Do not rush to toilet on sensation of urgency. Sit down and attempt 
relaxation plus 3-4 quick contractions of the pelvic floor muscles. When 
sensation passes, continue to toilet at a normal pace. 
o SUI- Contract pelvic floor muscles before and whilst carrying out activity 






This study found limited evidence for the use of eight types of non-pharmacological 
intervention for reducing daily episodes of urinary incontinence in older people. With the 
exception of group exercise therapy, there was generally little evidence of effect when these 
were used in isolation. However, when PFMT and bladder training were delivered in 
combination as a behavioural therapy, they appeared to provide greater benefit, leading to 
stronger evidence of effect in reducing episodes of incontinence. The relatively high degree 
of heterogeneity in the meta-analysis for behavioural therapy and bladder training probably 
reflects the range of different treatment protocols and study populations. Meta-analysis 
showed group exercise therapy reduced mean episodes of incontinence by 1.07 per day 
(95%CI 0.69-1.45) and behavioural therapy by 0.74 per day (95%CI 0.42-1.06), based on 
moderate quality of evidence according to GRADE. This makes these interventions 
approximately equally efficacious as antimuscarinic therapy for urgency incontinence [23] 
but without risking their adverse effects [24]. We therefore concluded the SENATOR 
software should make strong recommendations for both these therapies in the treatment of 
urinary incontinence in older persons.   
The findings from this review differ to a degree from current guidelines, perhaps because 
guidelines are not usually focused on older people’s needs specifically. The European 
Association of Urology (EAU) guidelines are, commendably, one of the few to include 
separate recommendations for older people [25], but these mostly emphasise the need for 
person-centred management rather than comprehensively reviewing and analysing the 
evidence-base in older people specifically. The National Institute for Health and Care 
Excellence (NICE) guidelines [26] recommends behavioural therapy only if bladder training 
is unsuccessful, while the EAU only makes recommendations for specific components of 
 
 
behavioural therapy. The American Urological Association (AUA) guidelines for stress 
urinary incontinence does not make any evidence-based recommendations at all, but 
recommends PFMT based on expert opinion [27]. Our findings suggest behavioural therapy 
should be more widely recommended for older people. Both EAU and NICE recommend 
bladder training for all women with incontinence but studies in older people are lacking. Our 
analysis suggest bladder training reduces daily episodes of incontinence by 0.77 episodes per 
day (95%CI 0.15-1.38) but the quality of evidence was down-graded to ‘low’ due to included 
studies having high risk of bias and inconsistency. This means future studies are likely to 
influence recommendations for practice and we could not make a recommendation for 
including bladder training in SENATOR recommendations. Our results are consistent with 
other similar systematic reviews that used different methodology or inclusion criteria but also 
found insufficient evidence to recommend bladder training [28-31]. AUA, EAU and NICE 
recommend supervised PFMT for all patients while this review found insufficient evidence of 
efficacy in older people, except where PFMT is delivered within a programme of group 
exercise therapy. A recent Cochrane review of PFMT also supports its use as first line 
therapy, but did not consider older people separately, nor did it differentiate between 
individual and group exercise [32]. In common with other reviews, we found little evidence 
to recommend other lifestyle interventions, such as reducing caffeine intake [33], despite 
their inclusion in the EAU and NICE guidelines [25,26].   
The review had a number of strengths and limitations relating to both the methods employed 
and the studies included in the review. Using the Delphi process helped identify the outcome 
of the highest importance to clinicians was included in the review. However, a major 
limitation is that the panel did not include patient representatives and not all clinicians had a 
special interest in incontinence specifically. Therefore, other important outcomes may have 
been excluded. The standardised method employed in all the ONTOP reviews ensures 
 
 
consistency and has already resulted in published evidence-based recommendations for non-
drug management in delirium [34], falls [35,36], stroke [37], pressure sores [38,39], 
behavioural disturbances in dementia [40], malnutrition [41] and sarcopenia [42]. This 
method also has the advantage of not pre-specifying interventions in the search terms, 
allowing evaluation of lesser-known interventions.  However, by identifying current 
systematic reviews as a source of primary trials, the risk of missing potentially informative 
trials was increased. Nevertheless, no further studies were found by hand-searching 
bibliographies of included reports, suggesting the search methods were robust. Only studies 
with a population mean age over 65 years were included. This is arguably a strength of the 
study in making its findings more relevant to a large proportion of people with incontinence, 
but it also risks neglecting potentially useful interventions that have only been tested in 
younger people. This is particularly important because only one study solely investigated 
older people. We also acknowledge that older people are a heterogenous group and it may 
have arguably been more clinically relevant to consider frailty or multi-morbidity rather than 
age. However, definitions of frailty vary and the management of incontinence in frailty is 
already considered in the latest International Consultation on Incontinence [43]. The current 
review includes limited evidence in men and a number of studies did not stratify populations 
by sex. This restricted the evidence and subsequent recommendations largely to women only. 
Excluding trials in specific conditions relating to incontinence may have resulted in selection 
bias. Finally, we limited the search to studies published in English but we did not identify any 




Group exercise therapy for stress incontinence and behavioural therapy incorporating bladder 
training, pelvic floor muscle training and practical tips to manage stress and urgency 
incontinence are beneficial in the management of urinary incontinence in older women. There 
was insufficient evidence to make recommendations in men or to recommend other forms of 
non-pharmacological therapy in older women.  
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Figure 1: PRISMA Flow Diagram 
Figure 2- Effect of group exercise therapy on number of episodes of incontinence/day 
Figure 3- Effect of behavioural therapy on number of episodes of incontinence/day 
Figure 4- Effect of bladder training on number of episodes of incontinence/day (Hu et al reported as 
mean change in episodes per day from baseline). 
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